The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Heart Lung Machines Market Research Report 2025
Synopsis
Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
The global Artificial Heart Lung Machines market was valued at US$ 278 million in 2023 and is anticipated to reach US$ 364.5 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
Global Artificial Heart Lung Machines key players include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%. And in terms of application, the largest application is Cardiac Surgery, followed by Lung Transplant Operation, Acute Respiratory Failure Treatment, etc.
This report aims to provide a comprehensive presentation of the global market for Artificial Heart Lung Machines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Heart Lung Machines.
Report Scope
The Artificial Heart Lung Machines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Heart Lung Machines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Heart Lung Machines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Segment by Type
Single Roller Pump HLM
Double Roller Pump HLM
Segment by Application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Heart Lung Machines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Heart Lung Machines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
The global Artificial Heart Lung Machines market was valued at US$ 278 million in 2023 and is anticipated to reach US$ 364.5 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
Global Artificial Heart Lung Machines key players include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%. And in terms of application, the largest application is Cardiac Surgery, followed by Lung Transplant Operation, Acute Respiratory Failure Treatment, etc.
This report aims to provide a comprehensive presentation of the global market for Artificial Heart Lung Machines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Heart Lung Machines.
Report Scope
The Artificial Heart Lung Machines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Heart Lung Machines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Heart Lung Machines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Segment by Type
Single Roller Pump HLM
Double Roller Pump HLM
Segment by Application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Heart Lung Machines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Heart Lung Machines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Artificial Heart Lung Machines Market Overview
1.1 Product Overview and Scope of Artificial Heart Lung Machines
1.2 Artificial Heart Lung Machines Segment by Type
1.2.1 Global Artificial Heart Lung Machines Market Value Comparison by Type (2024-2030)
1.2.2 Single Roller Pump HLM
1.2.3 Double Roller Pump HLM
1.3 Artificial Heart Lung Machines Segment by Application
1.3.1 Global Artificial Heart Lung Machines Market Value by Application: (2024-2030)
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Global Artificial Heart Lung Machines Market Size Estimates and Forecasts
1.4.1 Global Artificial Heart Lung Machines Revenue 2019-2030
1.4.2 Global Artificial Heart Lung Machines Sales 2019-2030
1.4.3 Global Artificial Heart Lung Machines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artificial Heart Lung Machines Market Competition by Manufacturers
2.1 Global Artificial Heart Lung Machines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artificial Heart Lung Machines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artificial Heart Lung Machines Average Price by Manufacturers (2019-2024)
2.4 Global Artificial Heart Lung Machines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Heart Lung Machines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Heart Lung Machines, Product Type & Application
2.7 Artificial Heart Lung Machines Market Competitive Situation and Trends
2.7.1 Artificial Heart Lung Machines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artificial Heart Lung Machines Players Market Share by Revenue
2.7.3 Global Artificial Heart Lung Machines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Heart Lung Machines Retrospective Market Scenario by Region
3.1 Global Artificial Heart Lung Machines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artificial Heart Lung Machines Global Artificial Heart Lung Machines Sales by Region: 2019-2030
3.2.1 Global Artificial Heart Lung Machines Sales by Region: 2019-2024
3.2.2 Global Artificial Heart Lung Machines Sales by Region: 2025-2030
3.3 Global Artificial Heart Lung Machines Global Artificial Heart Lung Machines Revenue by Region: 2019-2030
3.3.1 Global Artificial Heart Lung Machines Revenue by Region: 2019-2024
3.3.2 Global Artificial Heart Lung Machines Revenue by Region: 2025-2030
3.4 North America Artificial Heart Lung Machines Market Facts & Figures by Country
3.4.1 North America Artificial Heart Lung Machines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artificial Heart Lung Machines Sales by Country (2019-2030)
3.4.3 North America Artificial Heart Lung Machines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Heart Lung Machines Market Facts & Figures by Country
3.5.1 Europe Artificial Heart Lung Machines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artificial Heart Lung Machines Sales by Country (2019-2030)
3.5.3 Europe Artificial Heart Lung Machines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Heart Lung Machines Market Facts & Figures by Country
3.6.1 Asia Pacific Artificial Heart Lung Machines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artificial Heart Lung Machines Sales by Country (2019-2030)
3.6.3 Asia Pacific Artificial Heart Lung Machines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Artificial Heart Lung Machines Market Facts & Figures by Country
3.7.1 Latin America Artificial Heart Lung Machines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artificial Heart Lung Machines Sales by Country (2019-2030)
3.7.3 Latin America Artificial Heart Lung Machines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Heart Lung Machines Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Heart Lung Machines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artificial Heart Lung Machines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artificial Heart Lung Machines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Heart Lung Machines Sales by Type (2019-2030)
4.1.1 Global Artificial Heart Lung Machines Sales by Type (2019-2024)
4.1.2 Global Artificial Heart Lung Machines Sales by Type (2025-2030)
4.1.3 Global Artificial Heart Lung Machines Sales Market Share by Type (2019-2030)
4.2 Global Artificial Heart Lung Machines Revenue by Type (2019-2030)
4.2.1 Global Artificial Heart Lung Machines Revenue by Type (2019-2024)
4.2.2 Global Artificial Heart Lung Machines Revenue by Type (2025-2030)
4.2.3 Global Artificial Heart Lung Machines Revenue Market Share by Type (2019-2030)
4.3 Global Artificial Heart Lung Machines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artificial Heart Lung Machines Sales by Application (2019-2030)
5.1.1 Global Artificial Heart Lung Machines Sales by Application (2019-2024)
5.1.2 Global Artificial Heart Lung Machines Sales by Application (2025-2030)
5.1.3 Global Artificial Heart Lung Machines Sales Market Share by Application (2019-2030)
5.2 Global Artificial Heart Lung Machines Revenue by Application (2019-2030)
5.2.1 Global Artificial Heart Lung Machines Revenue by Application (2019-2024)
5.2.2 Global Artificial Heart Lung Machines Revenue by Application (2025-2030)
5.2.3 Global Artificial Heart Lung Machines Revenue Market Share by Application (2019-2030)
5.3 Global Artificial Heart Lung Machines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 LivaNova (Sorin)
6.1.1 LivaNova (Sorin) Corporation Information
6.1.2 LivaNova (Sorin) Description and Business Overview
6.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio
6.1.5 LivaNova (Sorin) Recent Developments/Updates
6.2 Getinge (Maquet)
6.2.1 Getinge (Maquet) Corporation Information
6.2.2 Getinge (Maquet) Description and Business Overview
6.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio
6.2.5 Getinge (Maquet) Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Artificial Heart Lung Machines Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo CV Group
6.4.1 Terumo CV Group Corporation Information
6.4.2 Terumo CV Group Description and Business Overview
6.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Terumo CV Group Artificial Heart Lung Machines Product Portfolio
6.4.5 Terumo CV Group Recent Developments/Updates
6.5 Braile Biomedica
6.5.1 Braile Biomedica Corporation Information
6.5.2 Braile Biomedica Description and Business Overview
6.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Braile Biomedica Artificial Heart Lung Machines Product Portfolio
6.5.5 Braile Biomedica Recent Developments/Updates
6.6 Tianjin Medical
6.6.1 Tianjin Medical Corporation Information
6.6.2 Tianjin Medical Description and Business Overview
6.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Tianjin Medical Artificial Heart Lung Machines Product Portfolio
6.6.5 Tianjin Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Heart Lung Machines Industry Chain Analysis
7.2 Artificial Heart Lung Machines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Heart Lung Machines Production Mode & Process
7.4 Artificial Heart Lung Machines Sales and Marketing
7.4.1 Artificial Heart Lung Machines Sales Channels
7.4.2 Artificial Heart Lung Machines Distributors
7.5 Artificial Heart Lung Machines Customers
8 Artificial Heart Lung Machines Market Dynamics
8.1 Artificial Heart Lung Machines Industry Trends
8.2 Artificial Heart Lung Machines Market Drivers
8.3 Artificial Heart Lung Machines Market Challenges
8.4 Artificial Heart Lung Machines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
